MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Cefalexin

Cefalexin 250mg capsules

Use with caution

Stability notes for Cefalexin 250mg capsules

Light sensitive medicine. Store in light resistant container.   Moisture sensitive medicine. Store in airtight (sealed) MCA.  No stability data in MCAs available.

Provenance

This recommendation is based on the products Cefalexin 250mg capsules (Aurobindo Pharma-Milpharm Ltd).

Suppliers (8) of Cefalexin 250mg capsules
Cefalexin 250mg capsules (A A H Pharmaceuticals Ltd)
Cefalexin 250mg capsules (Alliance Healthcare (Distribution) Ltd)
Cefalexin 250mg capsules (Flynn Pharma Ltd)
Cefalexin 250mg capsules (Medihealth (Northern) Ltd)
Cefalexin 250mg capsules (Milpharm Ltd)
Cefalexin 250mg capsules (Phoenix Healthcare Distribution Ltd)
Cefalexin 250mg capsules (Rudipharm Ltd)
Cefalexin 250mg capsules (Sigma Pharmaceuticals Plc)

Cefalexin 250mg tablets

No stability information

Stability notes for Cefalexin 250mg tablets

There are no stability notes for this medicine.

Suppliers (7) of Cefalexin 250mg tablets
Cefalexin 250mg tablets (A A H Pharmaceuticals Ltd)
Cefalexin 250mg tablets (Flynn Pharma Ltd)
Cefalexin 250mg tablets (Medihealth (Northern) Ltd)
Cefalexin 250mg tablets (Phoenix Healthcare Distribution Ltd)
Cefalexin 250mg tablets (Rudipharm Ltd)
Cefalexin 250mg tablets (Sigma Pharmaceuticals Plc)
Ceporex 250mg tablets (Crescent Pharma Ltd)

Cefalexin 500mg capsules

Use with caution

Stability notes for Cefalexin 500mg capsules

Light sensitive medicine. Store in light resistant container.   Moisture sensitive medicine. Store in airtight (sealed) MCA.  No stability data in MCAs available.

Provenance

This recommendation is based on the products Cefalexin 500mg capsules (Aurobindo Pharma-Milpharm Ltd).

Suppliers (8) of Cefalexin 500mg capsules
Cefalexin 500mg capsules (A A H Pharmaceuticals Ltd)
Cefalexin 500mg capsules (Alliance Healthcare (Distribution) Ltd)
Cefalexin 500mg capsules (Flynn Pharma Ltd)
Cefalexin 500mg capsules (Medihealth (Northern) Ltd)
Cefalexin 500mg capsules (Milpharm Ltd)
Cefalexin 500mg capsules (Phoenix Healthcare Distribution Ltd)
Cefalexin 500mg capsules (Rudipharm Ltd)
Cefalexin 500mg capsules (Sigma Pharmaceuticals Plc)

Cefalexin 500mg tablets

No stability information

Stability notes for Cefalexin 500mg tablets

There are no stability notes for this medicine.

Suppliers (6) of Cefalexin 500mg tablets
Cefalexin 500mg tablets (A A H Pharmaceuticals Ltd)
Cefalexin 500mg tablets (Flynn Pharma Ltd)
Cefalexin 500mg tablets (Medihealth (Northern) Ltd)
Cefalexin 500mg tablets (Phoenix Healthcare Distribution Ltd)
Cefalexin 500mg tablets (Rudipharm Ltd)
Cefalexin 500mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.